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INTRODUCTION
Insulin elicits many biological responses such as
cellular metabolism and gene expression. One of
the most important metabolic responses induced
by insulin is the stimulation of glucose uptake in
muscle and adipose tissues. This effect occurs as a
consequence of the translocation of GLUT4 from
the intracellular pool to the cell surface (1-4). Defect
of this function is thought to be one of the main
causes of non-insulin-dependent diabetes mellitus
(NIDDM). Therefore, elucidating the molecular
mechanism of GLUT4 translocation is important
for understanding the etiology of NIDDM.
To examine the mechanisms of GLUT4 trans-
location, we developed a sensitive and quantitative
method to measure directly c-myc epitope-tagged
GLUT4 (GLUT4myc) on the cell surface (5). Using
this system, we found that phosphatidylinositol
(PI) 3-kinase (p85/p110 heterodimer type) plays a
key role in GLUT4 translocation triggered by
insulin, by platelet-derived growth factor, and by
epidermal growth factor in cultured cells (6-8).
Activation of PI3-kinase is essential for insulin-
stimulated GLUT4 translocation and glucose
uptake (7). However, the downstream mediators of
PI3-kinase for GLUT4 translocation are still unknown.
One candidate molecule is Akt (Protein kinase B
or RAC/PK) (9-11). Akt is the cellular homologue
of a viral oncogene, v-Akt, and, has therefore also
been termed c-Akt (12). It has a PH (pleckstrin
homology) domain in the N-terminus which binds
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to other kinases (13). This PH domain shares
structural similarity with PKC (protein kinase C)
isozymes and PKA (cyclic AMP-dependent protein
kinase) (12). There are three isoforms of Akt ; Akt1
(PKBα), Akt 2 (PKBβ), and Akt 3 (PKBγ) (14-16).
Akt is rapidly activated by insulin and by certain
growth factors (17, 18). It is fully activated by
phosphorylation of two key regulatory amino acid
residues, Thr308 and Ser473 (19). Phosphatidylinositol
3,4,5-triphosphate-dependent protein kinase (PDK1)
phosphorylates Akt catalytic domain Thr308 and
activates Akt (20). There are two types of constitu-
tively active mutants of Akt ; viral Gag protein fused
type (21, 22) and myristoylation signal sequence
tagged type (23-25). Overexpression of these active
Akt promoted p70S6 kinase activity (10, 26),
GLUT4 translocation and glucose uptake (23, 24).
Overexpression of wild type Akt inhibited GSK3β
activity (17). However, Kitamura et al . reported that
Akt is not required for insulin-stimulated GLUT4
translocaiton or glucose uptake (27).
Therefore, we examined the effects of overex-
pressed WT Akt1 on insulin-stimulated GLUT4
translocation, glucose uptake, p70 S6kinase activity,
and GSK3β activity in L6 -GLUT4myc myotubes.
MATERIALS AND METHODS
Cells and materials
The parent cell line used in this study was L6-
GLUT4myc (28, 29). The HA-tagged mouse wild-type
Akt1 (30) was subcloned into a mammalian expres-
sion vector, pCXN (31). This plasmid was cotransfected
into L6-GLUT4myc cells with pSV2-hph (32), a
hygromycin B phosphotransferase expression plasmid
using lipofectamine reagent, and selected with
hygromycin B (Sigma). Two independent clones
were established, #203 and #2, to avoid clonal
deviations.
Cell surface anti-c-myc antibody binding assay
(GLUT4myc translocation assay)
Cells in 24-well plates were incubated in 500µl
of Krebs-Ringer-HEPES buffer (KRHB) (5) for 20
min at 37℃ and then with given concentrations of
ligands for 10 min at 37℃. GLUT4myc translocation
was measured as described (29).
2-Deoxyglucose Uptake Measurement
Cells in 24-well plates were treated with given
concentrations of ligands for 10 min at 37℃.
2-Deoxyglucose uptake was measured as described
previously (5).
Cell lysate and Immunoprecipitation
For Akt phosphorylation and kinase assays, cells
in 6 -well plates were incubated in KRH buffer for 30
min at 37℃, incubated in the absence or presence
of 10-7M insulin for 5 min at 37℃, lysed with buffer
containing 1% Nonidet P-40, sonicated and centrifuged
at 15,000 rpm for 15 min as described previously
(33), and the supernatants were incubated with
appropriate polyclonal antibodies for 2h at 4℃. The
immunocomplexes were precipitated with protein
A-Sepharose CL-4B (Amersham Pharmacia Biotech).
For p70S6K, GSK3β phosphorylation and kinase
assays, cells in 6 -well plates were deprived of serum
for 4 h, incubated in KRH buffer for 30 min at 37℃,
incubated in the absence or presence of 10-7M insulin
for 10 min at 37℃, lysed in a solution containing
50mM Hepes (pH7.5), 150mM NaCl, 1% TritonX-100,
20µM P-APMSF, 1mg/ml Bacitracin, 5mM EDTA,
5 mM EGTA, 1 mM Na pyrophosphate, 1 mM
Na3VO4, and 20 mM NaF, and immunoprecipitated
as described above.
Immunoblotting
Cell lysates were boiled for 5 min in Laemmli
sample buffer and subjected to SDS-polyacrylamide
gel electrophoresis ; the separated proteins were
transferred to nitrocellulose filter, probed with the
antibodies indicated below and detected as described
previously (34).
Antibodies
A monoclonal antibody (9E10) against human
c-myc was obtained from the American Type Culture
Collection. Phosphospecific Akt (Ser473), p70S6K
(Thr389), and GSK 3 α/β (Ser21/9) antibody were
purchased fromNew England Biolabs, Inc.. Anti-Akt1,
anti-p70S6K, and anti-GSK3β were prepared by im-
munizing rabbits with keyhole limpet hemocyanin-
coupled peptides, the COOH-terminal 20 amino
acids of Akt1 (CVDSERRPHFPQFSYSASGTA),
COOH-terminal 31 amino acids of p70S6K (MAG
VFDIDLDQPEDAGSEDELEEQQNLNESC), and
NH3-terminal 23 amino acids of GSK3β (CDTNA
GDRGQTNNAASASASNST).
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Analysis of Akt, p70S6K, and GSK3α/β Phos-
phorylations
Cells lysates were separated by 7% SDS-polyacrylamide
gel electrophoresis and immunoblotted with each
Phosphospecific antibody as described above.
Akt, p70S6K, and GSK3β kinase assays
For Akt kinase assays, the immunoprecipitates
were washed three times with washing buffer (i)
(140mM NaCl, 20mM Tris-HCl (pH 8.0), 1% Nonidet
P-40, and 1 mM DTT), and once with kinase buffer
(50mM Tris-HCl (pH7.5), 10mMMgCl2, 1mMDTT),
and incubated for 30 min at 30℃ in a reaction
mixture containing 1µM Protein kinase inhibitor,
160µM“Crosstide”(GRPRTSSFAEG) as substrate,
50mM Tris-HCl (pH7.5), 10mMMgCl2, 1mM DTT,
5µM unlabeled ATP, and 3.0µCi/µl [γ-32P] ATP.
The reaction was stopped by adding 10 µl of 250 mM
EDTA, and 5 mM ATP, and the reaction mixture
centrifuged at 15,000rpm for 1 min.. The resulting
supernatant (25 µl) was spotted onto 2×2 cm P81
(Whatman) filter paper, dryed and washed 15 min×
4 times with 75 mM phosphoric acid, and once with
99.5% Ethanol for 1 min. The 32P incorporation into
the peptide was determined by liquid scintillation
spectroscopy.
For p70S6 kinase assays, the immunoprecipitates
were washed three times with buffer containing 2M
LiCl, 82mM NaCl, 12mM Tris-HCl (pH 8.0), 0.58%
Nonidet P-40, and 580µM DTT, and washed twice
with kinase buffer (25mM MOPS (pH 7.2), 1mM
DTT, 6mM MgCl2, 1mM EDTA, and 0.05% Triton
X-100), and incubated for 30min at 30℃ in a reaction
mixture (25 µl) containing 1 µM Protein kinase
inhibitor, 200µM 40SR-pep20 (KRRRLASLRASYS
KSESSQK) as substrate, 25mM MOPS (pH 7.2),
1mM DTT, 6mM MgCl2, 1mM EDTA, and 0.05%
Triton X-100, 5 µM unlabeled ATP, and 3.0 µCi/µl
[γ-32P] ATP. The kinase activity was determined as
described above for Akt kinase assays.
For GSK3β kinase assays, the immunoprecipitates
were washed once with buffer (i), as described above,
washed twice with buffer (ii) (100 mM Tris-HCl
(pH 7.4), 0.5M LiCl, and 1mM DTT), and washed
twice with kinase buffer (20mM Hepes, 10mM
MgCl2, and 1mM DTT), and incubated for 30 min at
30℃ in a reaction mixture (25 µl) containing 2µM
Protein kinase inhibitor, 80 µM p-CREB (KRREIL
SRRP(p)SYR) as substrate, 16 mM Hepes, 8 mM
MgCl2, 0.8mM DTT, 35µM unlabeled ATP, and
3.0 µCi/µl [γ-32P]ATP. The kinase activity was deter-
mined as described above in Akt kinase assays.
RESULTS
Overexpression of WT Akt1 promoted the basal
and insulin-stimulated kinase activity of Akt in L6
myotubes
We transfected HA-tagged mouse WT Akt1 into
parent L6GLUT4myc cells, and established two
independent stable clones, #203 and #2. To confirm
the overexpression of WT Akt1, the cell lysate was
immunoblotted with a polyclonal anti-Akt1 anti-
body (Fig. 1A) and anti-HA antibody (Fig. 1B). The
exogenous mouse WT Akt1 was overexpressed at
about 5-fold the level of endogenous rat Akt1 in
L6GLUT4myc. Fig.1B shows that the lysates from
parent cells did not immunoreact with the HA anti-
body. To examine the activity of the exogenously
overexpressed WT Akt1 in L6 myotubes, we assessed
Akt phosphorylation (Fig. 2A) and kinase activity
after insulin stimulation (Fig.2B,C). Overexpression
of WT Akt1 promoted the insulin-stimulated Akt
phosphorylation of Ser 473 about 2-3 fold compared
to that of parent L6GLUT4myc cells (Fig. 2A).
Overexpression of WT Akt1 elevated basal Akt
Fig.1. Overexpression of wild-type (WT)
Akt1 in L6 myotubes.
A : Cell lysates were subjected to immunoblotting
with a polyclonal anti-Akt1 antibody. Lane
1 ; a band representing endogenous Akt in
L6GLUT4myc cells. Lane 2 and 3 ; endog-
enous Akt plus exogenously overexpressed
WT Akt1 in L6GLUT4mycAktWT#203 and
in L6GLUT4mycAktWT#2, respectively. By
scanning densitometry, the relative intensity
of these bands representing Akt in lanes
1-3 was 106, 633, and 580, respectively. B :
Immunoblotting with an anti-HA antibody to
show exogenously overexpressed WT Akt1.
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activity about 2-fold, and insulin-stimulated Akt
activity about 2-3 fold after immunoprecipitation
with anti-Akt1 antibody (Fig.2B). The activation
of exogenously expressed Akt1 was detected after
immunoprecipitation with anti-HA antibody (Fig.2C).
Overexpression of WT Akt1 promotes the insulin-
stimulated kinase activity of p70S6K in L6 myotubes
To examine the effect of overexpressed WT Akt1
on one of the downstream effectors, p70S6K, in
L6 myotubes, we assayed p70S6K phosphorylation
and the kinase activity after insulin stimulation
(Fig. 3A, B). Overexpression of WT Akt1 promoted
the insulin-stimulated p70S6K phosphorylation of
Thr 389 about 3-fold compared to that of parent
L6GLUT4myc cells (Fig.3A). The insulin-stimulated
p70S6 kinase activity was promoted by the over-
expression of WT Akt 1 about 2-3 fold compared to
that of parent cells (Fig. 3B).
Overexpression of WT Akt1 affects the basal kinase
activity of GSK 3β in L6 myotubes
GSK3β is a down stream target of Akt, and nega-
tively regulated by Akt-dependent phosphorylation
(17, 35). We assayed the phosphorylation and
activity of GSK3β kinase to examine whether the
exogenously overexpressed WT Akt1 affects the
GSK3β activity in the insulin signaling pathway.
The phosphorylations of GSK3α (Ser21) and GSK3β
(Ser9) were increased after insulin stimulation, and
were promoted by the overexpression of WT Akt1
in L6 myotubes (Fig. 4A). Stable overexpression of
Fig.2. Overexpression of WT Akt1 promoted the insulin-stimulated phosphorylation and kinase activity of Akt
in L6 myotubes.
A : Phosphorylation of Akt in L6 myotubes. Cells were incubated in the presence or absence of 10-7M insulin for 5 min at 37℃, lysed,
and subjected to immnunoblotting with an anti-phospho-specific Akt antibody. By scanning densitometry, the relative intensity of the
bands representing phosphorylated-Akt in lanes 2, 4, 6 was 612, 1150 and 1385, respectively.
B : Cells were incubated in the presence or absence of 10-7M insulin for 5 min at 37℃, lysed, immunoprecipitated with anti-Akt1
antibody, and subjected to Akt kinase assay.
C : Cells were incubated in the presence or absence of 10-7M insulin for 5 min at 37℃, lysed, immunoprecipitated with anti-HA
antibody, and subjected to Akt kinase assay. Values represent means±S.E. of three determinations.
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WT Akt1 results in about a 1.5̃1.7 fold increase of
basal GSK3β activity relative to that of parent cells
(Fig.4B) (see“Discussion”). Insulin-stimulated GSK3β
kinase activity was reduced about 43% in parental
cells (L6GLUT4myc) and about 28% in the cells
overexpressing WT Akt1 (#203, #2) (Fig. 4B). These
results indicated that overexpression of WT Akt1
affected the insulin-induced phosphorylation and
the inactivation of GSK3β.
WT Akt1 overexpression did not affect the GLUT4
translocation or glucose uptake in L6 myotubes
Exogenously overexpressed Akt in L6 myotubes
promoted insulin-stimulated Akt and p70S6K
activities. Overexpression of WT Akt1 promoted
Fig.3. Overexpression of WT Akt1 promoted the insulin-stimulated phosphorylation and kinase activity of
p70S6K in L6 myotubes.
A : Phosphorylation of p70S6K in L6 myotubes. Cells were incubated in the presence or absence of 10-7M insulin for 10 min at 37℃,
lysed, and subjected to immnunoblotting with an anti-phospho-specific p70S6K antibody (BioLabs). By scanning densitometry, the
relative intensity of the bands representing phosphorylated-p70S6K in lanes 2, 4, 6 was 569, 1577 and 1423, respectively.
B : Cells were incubated in the presence or absence of 10-7M insulin for 10 min at 37℃, lysed, immunoprecipitated with anti-p70S6K
antibody, and subjected to p70S6 kinase assay. Values represent means±S.E. of three determinations.
Fig.4. Effect of WT Akt1 overexpression on the phosphorylations and activities of GSK 3β in L6 myotubes.
A : Phosphorylation of GSK3α and GSK3β in L6 myotubes. Cells were incubated in the presence or absence of 10-7M insulin for 10 min
at 37℃, lysed, and subjected to immnunoblotting with an anti-phospho-specific GSK3 α/β antibody. By scanning densitometry, the
relative intensity of the bands representing phosphorylated-GSK3α in lanes 2, 4, 6 was 156, 225 and 224, and phospholyrated-GSK3β
in lanes 2, 4, 6 was 59, 89 and 86, respectively.
B : Cells were incubated in the presence or absence of 10-7M insulin for 10 min at 37℃, lysed, immunoprecipitated with anti-GSK3β
antibody, and subjected to GSK3 kinase assay. L6-GLUT4myc (open bars) ; L6-GLUT4myc Akt1WT#203 (diagonally striped bars) ;
L6-GLUT4myc Akt1WT#2 (closed bars). Values represent means±S.E. of three determinations.
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insulin-stimulated the phosphorylation (Ser 9) and
reduced the activity of GSK3β. We therefore exam-
ined insulin-stimulated GLUT4 translocation and
glucose uptake in L6 myotubes overexpressing
WT Akt1. Despite that exogenously overexpressed
WT Akt1 promoted insulin-stimulated Akt activity,
promoted p70S6K activity and reduced insulin-
stimulated GSK3β activity, no significant differences
of insulin-stimulated GLUT4 translocation or
insulin-stimulated glucose uptake were found between
L6GLUT4myc myotubes overexpressing WT Akt1
and parent L6GLUT4myc myotubes (Fig. 5A, B).
DISCUSSION
Overexpression of a constitutively active mutant
of Akt promoted GLUT4 translocation and glucose
uptake (21, 23, 24), while overexpression of a dominant
negative mutant of Akt inhibited the translocation
and uptake (23, 36). However, Kitamura et al. reported
that overexpression of a constitutively active mutant
of Akt and dominant negative mutant of Akt using
an adenovirus expression system did not affect
insulin-stimulated GLUT4 translocation or glucose
uptake (27). Therefore, the relationship between
Akt and insulin-stimulated GLUT4 translocation
and glucose uptake is still controversial. Further-
more, the effects of the dominant negative mutant of
Akt, in which at two phosphorylation sites (Thr308
and Ser473) the residue was changed to alanine, are
also controversial (25, 27, 36). We established stable
CHO cells which overexpressed the mutant Akt at
ten- fold the level of endogenous Akt, but a 10- fold
overexpression was not sufficient to inhibit endog-
enous insulin-stimulated Akt activation (data not
shown). Stable overexpression of functional dominant
negative mutant Akt might be difficult because
Akt is a mediator of cell survival which prevents
apoptosis (37). Therefore, we overexpressed wild
type Akt in this study. Although Akt negatively regu-
lated the activity of GSK3β by the phosphorylation
of Ser 9, the stable overexpression of WT Akt1
increased basal activity of GSK3β about 1.7-fold
compared to parent L6GLUT4myc cells (Fig. 4B).
The same results were obtained in CHO clones
(data not shown). The inconsistency of these results
may be explained by the functions of Akt. There
are several effectors of Akt and the regulation of
GSK3β activity might be quite complicated. We found
that overexpression of WT Akt1 in L6GLUT4myc
affected downstream effectors, such as p70S6 kinase
and GSK3β, but not GLUT4 translocation or glucose
uptake. These results, however, do not indicate wheth-
er Akt1 is a mediator of insulin-stimulated GLUT4
translocation and glucose uptake or not. Exogenous
expression of Akt1 does not affect the insulin-stimulated
GLUT4 translocation or glucose uptake, because
the level of endogenous Akt1 is sufficient mediate
this effect. This is not necessarily the case, however.
An approximately 2-fold increase in Akt activity was
observed in L6GLUT4myc cells after stimulation
Fig.5. Effect of WT Akt1 overexpression on the insulin-stimulated GLUT4 translocation and glucose uptake in
L6 myotubes.
L6 myoblasts in 24-well plates were differentiated into L6 myotubes by incubating with low serum, as described under MATERIALS
AND METHODS, and incubated with various concentrations of insulin for 10 min at 37℃. The GLUT4myc translocation (A) and
glucose uptake (B) were measured as described under MATERIALS AND METHODS. ○, parent L6-GLUT4myc cells ; ■,
L6-GLUT4myc Akt1 WT #203 ; ●, L6-GLUT4myc Akt1 WT #2. Values represent means±S.E. of six determinations.
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by insulin (Fig.2 B). The basal Akt activities in the
cells overexpressing WT Akt1 were two-fold higher
than the basal Akt activity of the parent cells (L6
GLUT4myc) (Fig.2B). However, there was no effect
on the basal level of GLUT4 translocation or glucose
uptake (Fig.5 B).
Our results indicated that Akt is not a main
signaling molecule to transmit between PI3-kinase
and insulin-stimulated GLUT 4 translocation.
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